A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
- Autor
- KASTRATI, Adnan1 ; MEHILLI, Julinda1 ; BERGER, Peter B6 ; SCHÖMIG, Albert1 2 ; SCHÜHLEN, Helmut1 ; DIRSCHINGER, Josef2 ; DOTZER, Franz3 ; TEN BERG, Jurriën M4 ; NEUMANN, Franz-Josef5 ; BOLLWEIN, Hildegard2 ; VOLMER, Christian1 ; GAWAZ, Meinrad1
[1] Deutsches Herzzentrum, Munich, Germany
[2] First Medizinische Klinik rechts der Isar, Munich, Germany
[3] Medizinische Klinik I, Garmisch-Partenkirchen, Germany
[4] St. Antonius Ziekenhuis, Nieuwegein, Netherlands
[5] Herz-Zentrum, Bad Krozingen, Germany
[6] Mayo Clinic, Rochester, Minn., United States
Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment (ISAR-REACT) Study Investigators - Fuente
The New England journal of medicine. 2004, Vol 350, Num 3, pp 232-238, 7 p ; ref : 29 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Campo Científico
- General medicine general surgery
- Editor
- Massachusetts Medical Society, Boston, MA
- País de la publicación
- United States
- Tipo de documento
- Article
- Idioma
- English
- Palabra clave (fr)
- Abciximab Angioplastie Association médicamenteuse Cardiopathie coronaire Chimiothérapie Clopidogrel Efficacité traitement Essai clinique Glycoprotéine IIbIIIa Homme Inhibiteur Prétraitement Traitement associé Voie percutanée Thiénopyridine dérivé Appareil circulatoire pathologie
- Palabra clave (in)
- Abciximab Angioplasty Drug combination Coronary heart disease Chemotherapy Clopidogrel Treatment efficiency Clinical trial Glycoprotein IIbIIIa Human Inhibitor Pretreatment Combined treatment Percutaneous route Cardiovascular disease
- Palabra clave (es)
- Abciximab Angioplastia Asociación medicamentosa Cardiopatía coronaria Quimioterapia Clopidogrel Eficacia tratamiento Ensayo clínico Glicoproteína IIbIIIa Hombre Inhibidor Pretratamiento Tratamiento asociado Vía percutánea Aparato circulatorio patología
- Clasificación
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02G Blood. Blood coagulation. Reticuloendothelial system
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B25 Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases / 002B25E Surgery of the heart
- Disciplina
- Pharmacological treatments Surgery. Transplants, organs and tissues grafting. Graft pathologies
- Procedencia
- Inist-CNRS
- Base de datos
- PASCAL
- Identificador INIST
- 15406488
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Acceso al documento
Install on your browser
DOI
10.1056/NEJMoa031859 
https://dx.doi.org/10.1056/NEJMoa031859
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"350\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"232\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"MEHILLI, Julinda\";i:1;s:15:\"BERGER, Peter B\";i:2;s:16:\"SCH\u00d6MIG, Albert\";i:3;s:17:\"SCH\u00dcHLEN, Helmut\";i:4;s:18:\"DIRSCHINGER, Josef\";i:5;s:13:\"DOTZER, Franz\";i:6;s:20:\"TEN BERG, Jurri\u00ebn M\";i:7;s:20:\"NEUMANN, Franz-Josef\";i:8;s:19:\"BOLLWEIN, Hildegard\";i:9;s:17:\"VOLMER, Christian\";i:10;s:14:\"GAWAZ, Meinrad\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"350\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"232\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"MEHILLI, Julinda\";i:1;s:15:\"BERGER, Peter B\";i:2;s:16:\"SCH\u00d6MIG, Albert\";i:3;s:17:\"SCH\u00dcHLEN, Helmut\";i:4;s:18:\"DIRSCHINGER, Josef\";i:5;s:13:\"DOTZER, Franz\";i:6;s:20:\"TEN BERG, Jurri\u00ebn M\";i:7;s:20:\"NEUMANN, Franz-Josef\";i:8;s:19:\"BOLLWEIN, Hildegard\";i:9;s:17:\"VOLMER, Christian\";i:10;s:14:\"GAWAZ, Meinrad\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Acceso mediante Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"350\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"232\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"MEHILLI, Julinda\";i:1;s:15:\"BERGER, Peter B\";i:2;s:16:\"SCH\u00d6MIG, Albert\";i:3;s:17:\"SCH\u00dcHLEN, Helmut\";i:4;s:18:\"DIRSCHINGER, Josef\";i:5;s:13:\"DOTZER, Franz\";i:6;s:20:\"TEN BERG, Jurri\u00ebn M\";i:7;s:20:\"NEUMANN, Franz-Josef\";i:8;s:19:\"BOLLWEIN, Hildegard\";i:9;s:17:\"VOLMER, Christian\";i:10;s:14:\"GAWAZ, Meinrad\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Europe PubMed Central
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"350\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"232\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"MEHILLI, Julinda\";i:1;s:15:\"BERGER, Peter B\";i:2;s:16:\"SCH\u00d6MIG, Albert\";i:3;s:17:\"SCH\u00dcHLEN, Helmut\";i:4;s:18:\"DIRSCHINGER, Josef\";i:5;s:13:\"DOTZER, Franz\";i:6;s:20:\"TEN BERG, Jurri\u00ebn M\";i:7;s:20:\"NEUMANN, Franz-Josef\";i:8;s:19:\"BOLLWEIN, Hildegard\";i:9;s:17:\"VOLMER, Christian\";i:10;s:14:\"GAWAZ, Meinrad\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Base Search
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1056\/NEJMoa031859\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2004\";s:9:\"\u0000*\u0000volume\";s:3:\"350\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"232\";s:8:\"\u0000*\u0000epage\";s:3:\"238\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"KASTRATI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Adnan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"MEHILLI, Julinda\";i:1;s:15:\"BERGER, Peter B\";i:2;s:16:\"SCH\u00d6MIG, Albert\";i:3;s:17:\"SCH\u00dcHLEN, Helmut\";i:4;s:18:\"DIRSCHINGER, Josef\";i:5;s:13:\"DOTZER, Franz\";i:6;s:20:\"TEN BERG, Jurri\u00ebn M\";i:7;s:20:\"NEUMANN, Franz-Josef\";i:8;s:19:\"BOLLWEIN, Hildegard\";i:9;s:17:\"VOLMER, Christian\";i:10;s:14:\"GAWAZ, Meinrad\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante arXiv
